Gyala Therapeutics initiates Phase I/ IIa clinical trial of a CAR-T cell therapy in acute leukemias with limited treatment options
Published on 03/19/2026 at 22:37 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/gyala-therapeutics-initiates-phase-iiia-clinical-trial-of-a-car-t-cell-therapy-in-acute-leukemias-with-limited-treatment-options-302681402.html
en | boerse | 68904738 |
